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Bio-Medical
 This invention is a means of delivering
a drug, or payload, to cells using non-co-
valent associations of the payload with
nano-engineered scaffolds; specifically,
functionalized single-walled carbon nano -
tubes (SWNTs) and their derivatives
where the payload is effectively sequest -
ered by the nanotube’s addends and
then delivered to the site (often interior
of a cell) of interest.
Polyethylene glycol (PEG) and other
water-soluble organic molecules have
been shown to greatly enhance the solu-
bility of SWNTs in water. PEG groups
and other water-solubilizing addends
can act to sequester (“sponge”) mole-
cules and deliver them into cells. Using
PEG that, when attached to the SWNTs,
the SWNT/PEG matrix will enter cells
has been demonstrated.  This was visual-
ized by the addition of fluorescein isoth-
iocyanate (FITC) to the SWNT/PEG
matrix. Control studies showed that
both FITC alone and FITC/PEG did not
enter the cells. These observations sug-
gest that the FITC is highly associated
with the SWNT/PEG matrix that brings
the FITC into the cells, allowing visuali-
zation of SWNTs in cells. 
The FITC is not covalently attached,
because extended dialysis in hot DMF
will remove all fluorescence quickly
(one week). However, prolonged dialysis
in water (1–2 months) will only slowly di-
minish the fluorescence. This demon-
strates that the SWNT/PEG matrix solu-
bilizes the FITC by sequestering it from
the surrounding water and into the
more solubilizing organic environment
of the SWNT/PEG matrix of this type.
This can be extended for the sequester-
ing of other molecules such as drugs
with PEG and other surfactants.
For example, it was shown that the
water-insoluble anti-cancer drug pacli-
taxel (Taxol) could be effectively dis-
solved in water via the sponging action
of the SWNT/PEG matrix in solution.
When one milligram of paclitaxel dis-
solved in 70 µL of ethanol is added into
1 mL of water, the drug will immediately
precipitate out of solution once in con-
tact with the water. However, when the
same amount of dissolved paclitaxel is
added into 1 mL of the SWNT/PEG ma-
trix solution in water, no paclitaxel pre-
cipitates out of solution. This is attrib-
uted to the paclitaxel being sequestered
from the water and into the more favor-
able SWNT/PEG matrix. In this way,
water-soluble solutions of paclitaxel
were made.
In preliminary studies, using the well
established MIT assay, the “sponged” pa-
clitaxel was shown to have comparable
cell-killing ability as the cremophor-sta-
bilized Taxol used in current clinical
cancer treatment. The SWNT/PEG ma-
trix, which was shown to be non-toxic to
cells, could be an effective alternative
for the drug delivery vehicle cremophor,
which is known to cause debilitating side
effects in some cancer patients. The
nano sponge should behave similarly in
the solubilization of other molecules
with limited or no water solubility. In ad-
dition, the material also serves as a pro-
tective barrier, sheltering the drug or
payload from premature destruction
within the body before it reaches the
final destination of the cell. Moreover,
one could simply add the functionalized
SWNTs into a solution of the drug or flu-
orescent tag of choice, incubate in order
to have the SWNT/PEG matrix se-
quester the drug or tag, and then admin-
ister the entire solution for delivery.
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Current sequencing-based and DNA
microarray techniques to study micro-
bial diversity are based on an initial
PCR (polymerase chain reaction) am-
plification step. However, a number of
factors are known to bias PCR amplifi-
cation and jeopardize the true repre-
sentation of bacterial diversity. PCR am-
plification of the minor template ap-
pears to be suppressed by the exponen-
tial amplification of the more abundant
template. It is widely acknowledged
among environmental molecular mi-
crobiologists that genetic biosignatures
identified from an environment only
represent the most dominant popula-
tions. The technological bottleneck has
overlooked the presence of the less
abundant “minority population,” and
underestimated their role in the ecosys-
tem maintenance. 
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To generate PCR amplicons for subse-
quent diversity analysis, bacterial l6S
rRNA genes are amplified by PCR using
universal primers. Two distinct PCR
regimes are employed in parallel: one
using normal and the other using biotin-
labeled universal primers. PCR products
obtained with biotin-labeled primers are
mixed with streptavidin-labeled mag-
netic beads and selectively captured in
the presence of a magnetic field. Less-
abundant DNA templates that fail to am-
plify in this first round of PCR amplifica-
tion are subjected to a second round of
PCR using normal universal primers.
These PCR products are then subjected
to downstream diversity analyses such as
conventional cloning and sequencing. A
second round of PCR amplified the mi-
nority population and completed the
deep diversity picture of the environ-
mental sample. 
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The benefits of applying a low sedi-
mental fluid shear environment to ma-
nipulate microorganisms were exam-
ined. Microorganisms obtained from a
low sedimental fluid shear culture,
which exhibit modified phenotypic and
molecular genetic characteristics, are
useful for the development of novel and
improved diagnostics, therapeutics, vac-
cines, and bio-industrial products. Fur-
thermore, application of low sedimental
fluid conditions to microorganisms per-
mits identification of molecules uni -
quely expressed under these conditions,
providing a basis for the design of new
therapeutic targets. 
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